Literature DB >> 4056850

A new technique to register proliferation of clonogenic cells from brain tumors.

G Unsgaard, B Larsen, A Dalen, R Vik, R Ringkjøb.   

Abstract

The soft agar technique for culturing human clonogenic tumor cells has been usefully applied for predicting individual clinical responses to chemotherapy, for screening of new antineoplastic drugs, and in basic biological research. The counting of colonies formed by clonogenic cells is, however, a rather time consuming and inaccurate procedure. We here report a method to combine the easy and precise registration of DNA-synthesis by 3H-thymidine incorporation with the ability of soft agar to permit proliferation of clonogenic cells and inhibit proliferation of non-neoplastic cells. The glioma cell lines U 251 MG and T-MG 1, the benignant glia cells T-BG 1, T-BG 2, T-BG 3 and fibroblasts were cultured in Furcellaran gel. Twenty hours before harvesting 3H-thymidine was added. The Furcellaran gel was resolved by 50 mM LiI. The cells were trapped on glass fiber filters and incorporated radioactivity was measured. 3H-thymidine incorporation in malignant cells increased exponentially with time, while 3H-thymidine incorporation in the benignant glia cells and fibroblasts was inhibited. The correlation between number of colonies counted after 16 days and 3H-thymidine incorporation registered after different culture times was very good. The correlation was best when the cultures were harvested after 8 days (r = 0.95), indicating that it is possible to reduce the assay time. The five glioma biopsies tested grew well with a mean plating efficiency of 0.4% (range 0.02-1.8%). The most intense proliferation seemed to take place during the first week in culture. The good correlation between 3H-thymidine incorporation on day 7 and colony number on day 14 (r = 0.93), indicate that reduction of assay time is possible also for the glioma biopsies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056850     DOI: 10.1007/BF00165180

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  9 in total

1.  Development of a clonogenic cell assay for human brain tumors.

Authors:  M L Rosenblum; D A Vasquez; T Hoshino; C B Wilson
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

Review 2.  Properties of human malignant glioma cells in vitro.

Authors:  J Pontén; B Westermark
Journal:  Med Biol       Date:  1978-08

3.  Colony growth and chemosensitivity in vitro of human melanoma biopsies. Relationship to clinical parameters.

Authors:  K M Tveit; O Fodstad; J Lotsberg; S Vaage; A Pihl
Journal:  Int J Cancer       Date:  1982-05-15       Impact factor: 7.396

4.  Stem cell studies of human malignant brain tumors. Part 1: Development of the stem cell assay and its potential.

Authors:  M L Rosenblum; M A Gerosa; C B Wilson; G R Barger; B F Pertuiset; N de Tribolet; D V Dougherty
Journal:  J Neurosurg       Date:  1983-02       Impact factor: 5.115

5.  Cultivation of human melanomas in soft agar. Factors influencing plating efficiency and chemosensitivity.

Authors:  K M Tveit; O Fodstad; A Pihl
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

6.  In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.

Authors:  D S Alberts; S E Samon; H S Chen; E A Surwit; B Soehnlen; L Young; T E Moon
Journal:  Lancet       Date:  1980-08-16       Impact factor: 79.321

7.  Primary bioassay of human tumor stem cells.

Authors:  A W Hamburger; S E Salmon
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

8.  Assessment of in vitro drug sensitivity of human tumor cells using [3H]thymidine incorporation in a modified human tumor stem cell assay.

Authors:  H M Friedman; D L Glaubiger
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

9.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents.

Authors:  V D Courtenay; J Mills
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

  9 in total
  5 in total

1.  An isotope agarose assay for rapid testing of the sensitivity of glioma biopsies to chemotherapeutic drugs and biological response modifiers. Effects of BCNU, vincristine, lymphokines and the recombinant agents interferon alpha 2c, interferon gamma and tumour necrosis factor.

Authors:  G Unsgaard; E Helseth; R Vik; A Dalen
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

2.  Overexpression of the epidermal growth factor receptor gene in a human carcinoma cell line, derived from a brain metastasis.

Authors:  E Helseth; A Dalen; G Unsgaard; R Vik; A Helseth
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

3.  Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line.

Authors:  E Helseth; A Dalen; G Unsgaard; R Vik
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

4.  The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line.

Authors:  E Helseth; G Unsgaard; A Dalen; R Vik
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

5.  Effects of type beta transforming growth factor in combination with retinoic acid or tumor necrosis factor on proliferation of a human glioblastoma cell line and clonogenic cells from freshly resected human brain tumors.

Authors:  E Helseth; G Unsgaard; A Dalen; R Vik
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.